A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)
Advanced esophageal squamous cell cancer (ESCC) is frequently diagnosed in elderly patients. The impact of 2nd line chemotherapy is poorly defined. Recent data demonstrated effectiveness of checkpoint inhibitors in different squamous cell carcinomas. Therefore, we assess combined nivolumab/ipilimuma...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
14 March 2019
|
| In: |
BMC cancer
Year: 2019, Volume: 19 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/s12885-019-5446-2 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12885-019-5446-2
|
| Author Notes: | Nadja M. Meindl-Beinker, Johannes Betge, Tobias Gutting, Elke Burgermeister, Sebastian Belle, Tianzuo Zhan, Nadine Schulte, Martin Maenz, Matthias P. Ebert and Nicolai Haertel |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1663067767 | ||
| 003 | DE-627 | ||
| 005 | 20210816113533.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190410s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12885-019-5446-2 |2 doi | |
| 035 | |a (DE-627)1663067767 | ||
| 035 | |a (DE-599)KXP1663067767 | ||
| 035 | |a (OCoLC)1264074564 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Meindl-Beinker, Nadja M. |d 1975- |e VerfasserIn |0 (DE-588)124950159 |0 (DE-627)368960056 |0 (DE-576)294584757 |4 aut | |
| 245 | 1 | 2 | |a A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA) |c Nadja M. Meindl-Beinker, Johannes Betge, Tobias Gutting, Elke Burgermeister, Sebastian Belle, Tianzuo Zhan, Nadine Schulte, Martin Maenz, Matthias P. Ebert and Nicolai Haertel |
| 264 | 1 | |c 14 March 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 10.04.2019 | ||
| 520 | |a Advanced esophageal squamous cell cancer (ESCC) is frequently diagnosed in elderly patients. The impact of 2nd line chemotherapy is poorly defined. Recent data demonstrated effectiveness of checkpoint inhibitors in different squamous cell carcinomas. Therefore, we assess combined nivolumab/ipilimumab as 2nd line therapy in elderly ESCC patients. | ||
| 700 | 1 | |a Betge, Johannes |d 1986- |e VerfasserIn |0 (DE-588)108257421X |0 (DE-627)847674347 |0 (DE-576)455525021 |4 aut | |
| 700 | 1 | |a Gutting, Tobias |d 1982- |e VerfasserIn |0 (DE-588)1165090708 |0 (DE-627)1029277370 |0 (DE-576)510243819 |4 aut | |
| 700 | 1 | |a Burgermeister, Elke |d 1968- |e VerfasserIn |0 (DE-588)173413455 |0 (DE-627)704732858 |0 (DE-576)184247551 |4 aut | |
| 700 | 1 | |a Belle, Sebastian |d 1976- |e VerfasserIn |0 (DE-588)134303415 |0 (DE-627)69224140X |0 (DE-576)278646646 |4 aut | |
| 700 | 1 | |a Zhan, Tianzuo |d 1985- |e VerfasserIn |0 (DE-588)1019998911 |0 (DE-627)691070105 |0 (DE-576)359019544 |4 aut | |
| 700 | 1 | |a Schulte, Nadine |d 1981- |e VerfasserIn |0 (DE-588)138942404 |0 (DE-627)703158511 |0 (DE-576)308939069 |4 aut | |
| 700 | 1 | |a Ebert, Matthias |d 1968- |e VerfasserIn |0 (DE-588)1030133522 |0 (DE-627)734827083 |0 (DE-576)377938432 |4 aut | |
| 700 | 1 | |a Härtel, Nicolai |d 1977- |e VerfasserIn |0 (DE-588)129912913 |0 (DE-627)483650609 |0 (DE-576)297899821 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC cancer |d London : BioMed Central, 2001 |g 19(2019) Artikel-Nummer 231, 8 Seiten |h Online-Ressource |w (DE-627)326643710 |w (DE-600)2041352-X |w (DE-576)107014645 |x 1471-2407 |7 nnas |a A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA) |
| 773 | 1 | 8 | |g volume:19 |g year:2019 |a A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA) |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12885-019-5446-2 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190410 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 129912913 |a Härtel, Nicolai |m 129912913:Härtel, Nicolai |d 60000 |d 61100 |e 60000PH129912913 |e 61100PH129912913 |k 0/60000/ |k 1/60000/61100/ |p 10 |y j | ||
| 998 | |g 1030133522 |a Ebert, Matthias |m 1030133522:Ebert, Matthias |d 60000 |d 61100 |e 60000PE1030133522 |e 61100PE1030133522 |k 0/60000/ |k 1/60000/61100/ |p 9 | ||
| 998 | |g 138942404 |a Schulte, Nadine |m 138942404:Schulte, Nadine |d 60000 |d 61100 |e 60000PS138942404 |e 61100PS138942404 |k 0/60000/ |k 1/60000/61100/ |p 7 | ||
| 998 | |g 1019998911 |a Zhan, Tianzuo |m 1019998911:Zhan, Tianzuo |d 60000 |d 61100 |e 60000PZ1019998911 |e 61100PZ1019998911 |k 0/60000/ |k 1/60000/61100/ |p 6 | ||
| 998 | |g 134303415 |a Belle, Sebastian |m 134303415:Belle, Sebastian |d 60000 |d 61100 |e 60000PB134303415 |e 61100PB134303415 |k 0/60000/ |k 1/60000/61100/ |p 5 | ||
| 998 | |g 173413455 |a Burgermeister, Elke |m 173413455:Burgermeister, Elke |d 60000 |d 61100 |e 60000PB173413455 |e 61100PB173413455 |k 0/60000/ |k 1/60000/61100/ |p 4 | ||
| 998 | |g 1165090708 |a Gutting, Tobias |m 1165090708:Gutting, Tobias |d 60000 |d 61100 |e 60000PG1165090708 |e 61100PG1165090708 |k 0/60000/ |k 1/60000/61100/ |p 3 | ||
| 998 | |g 108257421X |a Betge, Johannes |m 108257421X:Betge, Johannes |d 60000 |d 61100 |e 60000PB108257421X |e 61100PB108257421X |k 0/60000/ |k 1/60000/61100/ |p 2 | ||
| 998 | |g 124950159 |a Meindl-Beinker, Nadja M. |m 124950159:Meindl-Beinker, Nadja M. |d 60000 |d 61100 |e 60000PM124950159 |e 61100PM124950159 |k 0/60000/ |k 1/60000/61100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1663067767 |e 3421265631 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"14 March 2019","dateIssuedKey":"2019"}],"id":{"eki":["1663067767"],"doi":["10.1186/s12885-019-5446-2"]},"recId":"1663067767","relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.2001 -"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 22.05.20"],"title":[{"title_sort":"BMC cancer","title":"BMC cancer"}],"disp":"A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)BMC cancer","recId":"326643710","part":{"text":"19(2019) Artikel-Nummer 231, 8 Seiten","volume":"19","year":"2019"},"id":{"eki":["326643710"],"issn":["1471-2407"],"zdb":["2041352-X"]},"origin":[{"publisherPlace":"London ; Berlin ; Heidelberg","publisher":"BioMed Central ; Springer","dateIssuedKey":"2001","dateIssuedDisp":"2001-"}]}],"name":{"displayForm":["Nadja M. Meindl-Beinker, Johannes Betge, Tobias Gutting, Elke Burgermeister, Sebastian Belle, Tianzuo Zhan, Nadine Schulte, Martin Maenz, Matthias P. Ebert and Nicolai Haertel"]},"title":[{"title_sort":"multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)","title":"A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)"}],"person":[{"family":"Meindl-Beinker","given":"Nadja M.","role":"aut","display":"Meindl-Beinker, Nadja M."},{"role":"aut","given":"Johannes","family":"Betge","display":"Betge, Johannes"},{"role":"aut","given":"Tobias","family":"Gutting","display":"Gutting, Tobias"},{"family":"Burgermeister","given":"Elke","role":"aut","display":"Burgermeister, Elke"},{"family":"Belle","role":"aut","given":"Sebastian","display":"Belle, Sebastian"},{"display":"Zhan, Tianzuo","family":"Zhan","given":"Tianzuo","role":"aut"},{"display":"Schulte, Nadine","family":"Schulte","given":"Nadine","role":"aut"},{"display":"Ebert, Matthias","family":"Ebert","role":"aut","given":"Matthias"},{"family":"Härtel","role":"aut","given":"Nicolai","display":"Härtel, Nicolai"}],"language":["eng"],"note":["Gesehen am 10.04.2019"],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a MEINDLBEINMULTICENTE1420 | ||